About
Asylia was founded in 2019 to respond to the growing need for diagnostics solutions.
Asylia has set up a multi-disciplinary scientific team uniquely positioned to deliver precision medicine tools thanks to a combination of technical, biological, and laboratory skills acquired from over 40+ combined years of experience in research and leading biopharma companies. The team has further developed a specific technical background in the development of biomarker discovery, molecular biology, immunology, clinical sciences and AI building with direct applications to the field of oncology.
Andrey Khmelevskiy
The CEO, Co-Founder, Andrey Khmelevskiy, has over 15 years of experience as a manager and entrepreneur in the data sciences and bioinformatics field. He held executive roles at Saudi Aramco, InsideDNA, Exclusive Analysis, JP Kenny, Frecom and Wiltshire Council.
Dr. Anna Kostikova
Dr. Anna Kostikova, Co-Founder, has over 15 years of experience in managerial roles in pharma and multinational companies. She serves as a Director of Data Science at Novartis and led data science teams at Deloitte, InsideDNA, Booking.com and Heineken.
Dr. Yulia Mitina
Dr. Yulia Mitina, Head of Clinical Operations, is a seasoned MIT certified clinician with 5+ years of experience in leading the development of multiple clinical studies in the fields of molecular biology and immunology.
Dr. Anna Valyaeva
Dr. Anna Valyaeva, Head of Computational Biology, has a strong coding background and various experiences in the molecular biology field. With her experience in managing NGS bioinformatics, she will manage the development of Asylia AI software.
Dr. Alexey Churov
Dr. Alexey Churov Head of Immunology 15+ years of experience in immuno-oncology & autoimmune disorders; publications track record
